'Pharma Bro' Martin Shkreli is ordered to return $64M, barred from drug industry
Martin Shkreli, who is serving a seven-year prison sentence for fraud, must return profits he and his former company reaped from raising the price of a life-saving drug, a federal judge ruled.
Jan 14, 2022
2 minutes
NEW YORK — must return $64.6 million in profits he and his former company reaped from raising the price of the life-saving drug Daraprim, a federal judge ruled Friday while also barring the provocative, imprisoned ex-CEO from participating in the pharmaceutical industry for
You’re reading a preview, subscribe to read more.
Start your free 30 days